‘Faslodex’ (ICI 182,780) 250 mg shows consistent pharmacokinetic profile when given as either a one × 5-ml intra-muscular (i.m) injection or two × 2.5-ml injections in postmenopausal (PM) women with advanced breast cancer (ABC)
- 30 April 2001
- journal article
- abstracts
- Published by Elsevier in European Journal Of Cancer
- Vol. 37, S198
- https://doi.org/10.1016/s0959-8049(01)81215-6
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: